...
首页> 外文期刊>Journal of cellular physiology. >HCMV modulates c-Mpl/IEX-1 pathway-mediated megakaryo/ thrombopoiesis via PDGFRα and αvβ3 receptors after allo-HSCT
【24h】

HCMV modulates c-Mpl/IEX-1 pathway-mediated megakaryo/ thrombopoiesis via PDGFRα and αvβ3 receptors after allo-HSCT

机译:调节血巨细胞病毒c-Mpl / IEX-1 pathway-mediated受体后allo-HSCT

获取原文
获取原文并翻译 | 示例
           

摘要

Thrombocytopenia is a common complication of human cytomegalovirus (HCMV) infection in immunocompromised hosts, which contributes to poor prognosis even in patients receiving antiviral treatment. Here, we investigated the megakaryo/thrombopoiesis process, including the involvement of the c-Mpl/IEX-1 pathway, after HCMV infection, identified receptors mediating the interaction between megakaryocytes (MKs) and HCMV, and explored novel therapeutic targets. Our data shows that HCMV directly infects megakaryocytes in patients with HCMV DNAemia and influences mega-karyopoiesis via the c-Mpl/IEX-1 pathway throughout megakaryocyte maturation, apoptosis, and platelet generation in vivo and in vitro. After treatment with inhibitors of PDGFRα and αvβ3, the HCMV infection rate in MKs was significantly reduced, suggesting that IMC-3G3 and anti-av(33 are potential therapeutic alternatives for viral infection. In summary, our study proposes a possible mechanism and potential treatments for thrombocytopenia caused by HCMV infection and other viral diseases associated with abnormal hemostasis.
机译:血小板减少症是一种常见的并发症巨细胞病毒()血巨细胞病毒感染免疫力低下的宿主,导致即使在患者预后不良抗病毒治疗。megakaryo /血栓形成过程,包括参与c-Mpl / IEX-1通路,之后感染,血巨细胞病毒识别受体介导巨核细胞之间的交互(MKs)和,血巨细胞病毒和探索新的治疗目标。数据显示,直接血巨细胞病毒感染巨核细胞和DNAemia血巨细胞病毒患者通过c-Mpl / IEX-1 mega-karyopoiesis影响在巨核细胞成熟通路,细胞凋亡,体内血小板生成体外。v和αβ3,MKs的感染率血巨细胞病毒显著降低,表明IMC-3G3和选择投票制(33是潜在的治疗病毒感染的替代品。和潜在的研究提出了一种可能的机制治疗血小板减少引起的。血巨细胞病毒感染和其它病毒性疾病相关与异常的止血。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号